Skip to main content
. 2016 Sep 27;15(6):495–501. doi: 10.2450/2016.0107-16

Table III.

Epidemiological data on HIV, HCV and HBV screening in the PDS setting 2010–2013.

Country Newly registered blood donors First time donations Repeat donations
Number HIV HCV HBV Number HIV HCV HBV Number HIV HCV HBV
Total (prev./105) Recent (prev./105) Total (prev./105) Recent (prev./105) Total (prev./105) Recent (prev./105) Total (prev./105) Total (prev./105) Total (prev./105) Total (prev./105) Total (prev./105) Total (prev./105)
Ireland 5,369 0 (0.0) 0 (0.0) 10 (186.3) 0 (0.0) 11 (204.9) 0 (0.0) NA NA NA NA NA NA NA NA
Italy* 580,988 74 (12.7) NA 428 (73.7) NA 758 (130.5) NA 394,892 8 (2.02) 5 (1.26) 21 (5.31) NA NA NA NA
Netherlands 140,972 2 (1.4) 0 (0.0) 20 (14.2) 0 (0.0) 57 (40.4) 6 (4.3) 107,599 0 0 0 3,259,611 5 (0.2) 1 (0.003) 17 (0.5)
Norway** 73,774 1 (1.4) NA 32 (43.4) NA 27 (36.6) NA NA NA NA NA 860,125 0 (0.0) 3 (0.3) 1 (0.1)
Sweden** 175,458 1 (0.6) NA 73 (41.6) NA 58 (33.1) NA NA NA NA NA 1,950,956 1 (0.1) 11 (0.6) 3 (0.2)
Total 976,561 78 (7.9) NA 563 (57.6) NA 911 (93.3) NA NA NA NA NA NA NA NA NA

NA: not available;

*

newly-registered donors not tested with NAT;

**

donations not tested with NAT; prev.: prevalence. HIV: human immunodeficiency virus; HCV: hepatitis C virus; HBV: hepatitis B virus; PDS: pre-donation and donation screening.